Baillie Gifford & CO Nanobiotix S.A. Transaction History

Baillie Gifford & CO

  • $131 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024
BUY
$5.34 - $9.19 $4.98 Million - $8.57 Million
932,835 Added 48.18%
2,869,030 $20.9 Million
Q3 2023

Nov 13, 2023
BUY
$5.03 - $10.76 $2.7 Million - $5.77 Million
536,195 Added 38.3%
1,936,195 $16.9 Million
Q4 2020

Feb 10, 2021
BUY
$15.95 - $19.4 $22.3 Million - $27.2 Million
1,400,000 New
1,400,000 $23.1 Million

Others Institutions Holding NBTX

# of Institutions
11
Shares Held
6.43M
Call Options Held
0
Put Options Held
0
View Full List

About Nanobiotix S.A.

NBTX Quotes by TradingView
  • Ticker NBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,875,900
  • Market Cap $142M
  • Description
  • Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...
More about NBTX
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email